Trump Admin Unveils New Medicaid Drug Pricing Initiatives

1 min read
Source: The Hill
Trump Admin Unveils New Medicaid Drug Pricing Initiatives
Photo: The Hill
TL;DR Summary

The Trump administration's CMS is launching a five-year pilot in 2026 to link Medicaid drug prices to lower international prices through a 'Most Favored Nation' model, allowing participating states to negotiate lower prices for certain drugs, amid ongoing debates about its impact on drug costs and rebates.

Share this article

Reading Insights

Total Reads

0

Unique Readers

0

Time Saved

4 min

vs 4 min read

Condensed

94%

74847 words

Want the full story? Read the original article

Read on The Hill